Christopher Verni
General Counsel bei VIGIL NEUROSCIENCE, INC.
Vermögen: 12 720 $ am 31.05.2024
Aktive Positionen von Christopher Verni
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| VIGIL NEUROSCIENCE, INC. | General Counsel | 20.04.2022 | - |
Karriereverlauf von Christopher Verni
Ehemalige bekannte Positionen von Christopher Verni
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SAREPTA THERAPEUTICS, INC. | Corporate Officer/Principal | 01.12.2013 | 01.04.2022 |
| ARIAD PHARMACEUTICALS, INC. | General Counsel | 01.10.2011 | 01.11.2013 |
| Sanofi SA | General Counsel | 01.05.2007 | 01.10.2011 |
| PFIZER, INC. | General Counsel | 01.05.2004 | 01.05.2007 |
Ausbildung von Christopher Verni
| University of New Hampshire School of Law | Graduate Degree |
| Rochester Christian University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 7 |
| Frankreich | 2 |
Operativ
| General Counsel | 4 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 6 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| VIGIL NEUROSCIENCE, INC. | Health Technology |
| SAREPTA THERAPEUTICS, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
| Sanofi SA | Health Technology |
- Börse
- Insiders
- Christopher Verni
- Erfahrung